Published in Proc Natl Acad Sci U S A on April 17, 2001
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer (2010) 4.08
IAPs: what's in a name? Mol Cell (2008) 3.66
XIAP discriminates between type I and type II FAS-induced apoptosis. Nature (2009) 3.00
Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol (2005) 2.57
Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev (2008) 1.63
Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ (2011) 1.63
Cloning and characterization of the rat homologues of the Inhibitor of Apoptosis protein 1, 2, and 3 genes. BMC Genomics (2002) 1.18
Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades. Curr Cancer Drug Targets (2009) 1.00
Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. J Exp Med (2003) 0.91
Role for X-linked Inhibitor of apoptosis protein upstream of mitochondrial permeabilization. J Biol Chem (2009) 0.90
Death pathways in T cell homeostasis and their role in autoimmune diabetes. Rev Diabet Stud (2006) 0.85
Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells. Cell Death Differ (2010) 0.83
Apoptosis by death factor. Cell (1997) 14.42
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science (1999) 11.96
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell (1991) 8.13
Caspases: intracellular signaling by proteolysis. Cell (1997) 7.46
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (1996) 7.27
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23
Cell death in development. Cell (1999) 6.01
Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell (1998) 5.92
Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell (1990) 4.84
Fas and Fas ligand: lpr and gld mutations. Immunol Today (1995) 4.69
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature (1996) 4.55
The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene (1998) 3.98
Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J (1990) 3.62
Negative selection of lymphocytes. Cell (1994) 3.47
Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell (1997) 3.13
Positive selection of lymphocytes. Cell (1994) 2.86
Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22
Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med (1999) 2.12
In vitro stimulation of mouse thymus cells by PHA and allogeneic cells. Cell Immunol (1971) 1.94
Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature (1994) 1.88
Participation of Bir1p, a member of the inhibitor of apoptosis family, in yeast chromosome segregation events. Proc Natl Acad Sci U S A (1999) 1.69
Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med (1995) 1.59
Changes in the relative abundance of type I and type II lck mRNA transcripts suggest differential promoter usage during T-cell development. Mol Cell Biol (1990) 1.29
Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast. J Biol Chem (2000) 1.29
XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage. J Biol Chem (2000) 1.22
The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus. J Exp Med (1994) 1.05
Thymus-derived glucocorticoids regulate antigen-specific positive selection. J Exp Med (1997) 1.02
Thymocyte apoptosis. J Clin Immunol (1999) 0.81
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (1998) 11.70
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature (1996) 4.55
The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene (1998) 3.98
Physical and genetic mapping of a novel chromosome 19 ERCC1 marker showing close linkage with myotonic dystrophy. Genomics (1991) 3.72
Isolation of cDNA clones coding for the beta subunit of human beta-hexosaminidase. Proc Natl Acad Sci U S A (1985) 3.50
Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet (1992) 3.39
Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A (2008) 3.27
IAP-targeted therapies for cancer. Oncogene (2008) 3.09
A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol (1999) 2.84
Isolation of human fibroblast catalase cDNA clones. Sequence of clones derived from spliced and unspliced mRNA. J Biol Chem (1984) 2.57
Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem (1986) 2.54
The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis (1996) 2.35
XIAP: apoptotic brake and promising therapeutic target. Apoptosis (2001) 2.28
Rapid and reliable dideoxy sequencing of double-stranded DNA. Gene (1985) 2.24
Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol (2000) 2.22
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature (1990) 2.20
EFFECTS OF PHOSPHORUS AND LIME IN REDUCING ALUMINUM TOXICITY OF ACID SOILS. Plant Physiol (1937) 2.20
Internal ribosome initiation of translation and the control of cell death. Trends Genet (2000) 2.17
Isolation and characterization of the human catalase gene. Nucleic Acids Res (1986) 2.12
Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol (2001) 2.02
Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.93
Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene (2000) 1.93
A model to accumulate fractionated dose in a deforming organ. Int J Radiat Oncol Biol Phys (1999) 1.80
Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat Genet (1993) 1.79
Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol (2000) 1.74
XIAP, the guardian angel. Nat Rev Mol Cell Biol (2001) 1.72
A national survey of athletic trainer roles and responsibilities in the allied clinical setting. J Athl Train (1992) 1.68
Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys (2000) 1.67
The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation. Phys Med Biol (1998) 1.55
Aluminium and fluoride concentrations of three tea varieties growing at Lantau Island, Hong Kong. Environ Geochem Health (2003) 1.50
A performance comparison of flat-panel imager-based MV and kV cone-beam CT. Med Phys (2002) 1.42
High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation. Hum Mol Genet (1994) 1.40
The effect of using shorter echo times in MR imaging of knee menisci: a study using a porcine model. AJR Am J Roentgenol (1999) 1.39
Clinical use of electronic portal imaging: report of AAPM Radiation Therapy Committee Task Group 58. Med Phys (2001) 1.37
A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets. Int J Radiat Oncol Biol Phys (1999) 1.37
Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology (2001) 1.36
Assessment of trace metal distribution and contamination in surface soils of Hong Kong. Environ Pollut (1997) 1.36
Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics (2000) 1.33
The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy. Am J Hum Genet (1990) 1.31
cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ (2012) 1.29
Characterization of large CTG repeat expansions in myotonic dystrophy alleles using PCR. Hum Mutat (1996) 1.28
Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol (2001) 1.28
Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med (1997) 1.24
A comprehensive system for dosimetric commissioning and Monte Carlo validation for the small animal radiation research platform. Phys Med Biol (2009) 1.21
Reduction in size of the myotonic dystrophy trinucleotide repeat mutation during transmission. Science (1993) 1.20
Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res (1996) 1.19
Intergenerational stability of the myotonic dystrophy protomutation. Hum Mol Genet (1993) 1.19
Monitor unit settings for intensity modulated beams delivered using a step-and-shoot approach. Med Phys (2000) 1.16
Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci (1999) 1.16
Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br J Cancer (2012) 1.15
An assessment of learning styles among undergraduate athletic training students. J Athl Train (1998) 1.14
Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM). Hum Genet (1989) 1.13
Delphi Study: HIV/AIDS and the Athletic Population. J Athl Train (1994) 1.13
Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II. Proc Natl Acad Sci U S A (1985) 1.13
Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells. Oncogene (2006) 1.11
Genomic organization of the X-linked inhibitor of apoptosis and identification of a novel testis-specific transcript. Genomics (2001) 1.11
Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ (1999) 1.11
IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nat Cell Biol (2002) 1.10
Linkage analysis of the apolipoprotein C2 gene and myotonic dystrophy on human chromosome 19 reveals linkage disequilibrium in a French-Canadian population. Am J Hum Genet (1989) 1.10
Genomic organization and primary characterization of miap-3: the murine homologue of human X-linked IAP. Genomics (1997) 1.09
Genomic characterization of the mouse inhibitor of apoptosis protein 1 and 2 genes. Genomics (1997) 1.08
Iatrogenic spondylolysis leading to contralateral pedicular stress fracture and unstable spondylolisthesis: a case report. Spine (Phila Pa 1976) (2000) 1.08
Physical and genetic characterization of the distal segment of the myotonic dystrophy area on 19q. Genomics (1992) 1.06
Streptococcal necrotizing myositis: the role of magnetic resonance imaging. A case report. J Bone Joint Surg Am (2001) 1.05
A software tool for the quantitative evaluation of 3D dose calculation algorithms. Med Phys (1998) 1.05
Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem (2000) 1.02
Isolation and expression in Escherichia coli of a cDNA clone encoding human beta-glucuronidase. Gene (1985) 1.02
The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury. Proc Natl Acad Sci U S A (2000) 1.01
Revegetation of lagoon ash using the legume species Acacia auriculiformis and Leucaena leucocephala. Environ Pollut (2000) 1.01
Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2. Mamm Genome (1999) 1.00
Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys (1999) 1.00
Effects of gravity on tracheal mucus transport rates in normal subjects and in patients with cystic fibrosis. Pediatrics (1977) 0.99
An RFLP associated with the human catalase gene. Nucleic Acids Res (1985) 0.99
Osteochondroma and secondary synovial osteochondromatosis. Skeletal Radiol (1999) 0.98
Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol (2000) 0.98
Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J Antibiot (Tokyo) (1998) 0.97
Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis (1997) 0.97
Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys (2000) 0.96
Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: implications for genetic counselling and genetic anticipation. Am J Med Genet (1993) 0.96
Characterization and polymerase chain reaction (PCR) detection of an Alu deletion polymorphism in total linkage disequilibrium with myotonic dystrophy. Genomics (1993) 0.96
The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ (2000) 0.95
Use of computer-based instruction in athletic training education. J Athl Train (1996) 0.95
Assignment of human inhibitor of apoptosis protein (IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization. Genomics (1996) 0.94
The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains. J Infect Dis (1999) 0.93
Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J Neurochem (1999) 0.93
Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae. Clin Infect Dis (2000) 0.93
Removal of heavy metals from anaerobically digested sewage sludge by isolated indigenous iron-oxidizing bacteria. Chemosphere (2000) 0.92
SMA genes: deleted and duplicated. Nat Genet (1995) 0.92
Definition of regulatory sequence elements in the promoter region and the first intron of the myotonic dystrophy protein kinase gene. J Biol Chem (1998) 0.92
Somatostatin gene expression in pancreatic islet cells is directed by cell-specific DNA control elements and DNA-binding proteins. J Biol Chem (1989) 0.92
Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiol Dis (2003) 0.91
Overexpression of 3'-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblast differentiation in vitro. J Biol Chem (1997) 0.91